Intend Research is a clinical research site located in Norman, Oklahoma, United States 73069.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Intend Research has participated in 18 clinical trials.
Therapeutic areas: Type2 Diabetes, Dyslipidemia, Diabetes Mellitus, Type 2.
Sponsors: Kowa Research Institute, Inc., Intarcia Therapeutics, Eli Lilly and Company.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Intend Research has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Intend Research has 18 clinical trials on record. Their work covers Type2 Diabetes, Dyslipidemia, Diabetes Mellitus, Type 2.
Yes — Intend Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.